Clovis Oncology Inc (NASDAQ:CLVS)

0.3459
Delayed Data
As of Nov 25
 +0.0059 / +1.74%
Today’s Change
0.23
Today|||52-Week Range
3.33
-87.24%
Year-to-Date

Today’s Trading

Previous close0.34
Today’s open0.33
Day’s range0.32 - 0.35
Volume16,234
Average volume (3 months)3,893,122
Market cap$47.5M
Data as of 12:46pm ET, 11/25/2022

Growth & Valuation

Earnings growth (last year)+47.72%
Earnings growth (this year)+32.70%
Earnings growth (next 5 years)+27.85%
Revenue growth (last year)-9.58%
P/E ratioNM
Price/Sales2.10
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TCRRTCR2 Therapeutics In...+0.02+1.57%
INFIInfinity Pharmaceuti...-0.01-1.50%
AQSTAquestive Therapeuti...-0.01-1.00%
AKBAAkebia Therapeutics ...-0.00-0.54%
Data as of 1:00pm ET, 11/25/2022

Financials

Last reporting dateNovember 25, 2022
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$148.8M
Annual profit (last year)-$264.5M
Net profit margin-177.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Boulder, Colorado

Forecasts